Functional anatomy, fine structure and basic pathology of the retinal vasculature

Retinal Vascular Disease

Volumn , Issue , 2007, Pages 3-23

  Archer, Desmond B ^a   Gardiner, Tom A ^a   Stitt, Alan W ^a  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 79954698633     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-3-540-29542-6_1     Document Type: Chapter

References (41)

1. Alder VA, Su EN, et al. (1998) Overview of studies on metabolic and vascular regulatory changes in early diabetic reti-nopathy. Aust N Z J Ophthalmol 26(2):141-148
2. Alon T, Hemo I, et al. (1995) Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity. Nat Med 1(10):1024-1028
3. Antonetti DA, Lieth E, et al. (1999) Molecular mechanisms of vascular permeability in diabetic retinopathy. Semin Ophthalmol 14(4):240-248
4. Beltramo E, Pomero F, et al. (2002) Pericyte adhesion is impaired on extracellular matrix produced by endothelial cells in high hexose concentrations. Diabetologia 45(3): 416-419
5. Bresnick GH, Davis MD, et al. (1977) Clinicopathologic correlations in diabetic retinopathy. II. Clinical and histologic appearances of retinal capillary microaneurysms. Arch Ophthalmol 95(7):1215-1220
6. Chakravarthy U, Gardiner TA (1999) Endothelium-derived agents in pericyte function/dysfunction. Prog Retin Eye Res 18(4):511-527
7. Chan-Ling T, Gock B, et al. (1995) The effect of oxygen on vasoformative cell division. Evidence that 'physiological hypoxia' is the stimulus for normal retinal vasculogenesis. Invest Ophthalmol Vis Sci 36(7):1201-1214
8. Claxton S, Fruttiger M (2003) Role of arteries in oxygen induced vaso-obliteration. Exp Eye Res 77(3):305-311
9. Dery MA, Michaud MD, et al. (2005) Hypoxia-inducible factor 1: regulation by hypoxic and non-hypoxic activators. Int J Biochem Cell Biol 37(3):535-540
10. Frank RN, Dutta S, et al. (1987) Pericyte coverage is greater in the retinal than in the cerebral capillaries of the rat. Invest Ophthalmol Vis Sci 28(7):1086-1091
11. Gardiner TA, Stitt AW, et al. (1994) Selective loss of vascular smooth muscle cells in the retinal microcirculation of diabetic dogs. Br J Ophthalmol 78(1):54-60
12. Gardner TW, Antonetti DA, et al. (2000) New insights into the pathophysiology of diabetic retinopathy: potential cell-specific therapeutic targets. Diabetes Technol Ther 2(4):601-608
13. Garner A, Ashton N (1979) Pathogenesis of hypertensive retinopathy: a review. J R Soc Med 72(5):362-365
14. Grunwald JE, Riva CE, et al. (1984) Altered retinal vascular response to 100% oxygen breathing in diabetes mellitus. Ophthalmology 91(12):1447-1452
15. Janzer RC, Raff MC (1987) Astrocytes induce blood-brain barrier properties in endothelial cells. Nature 325(6101): 253-257
16. Kohner EM, Henkind P (1970) Correlation of fluorescein angiogram and retinal digest in diabetic retinopathy. Am J Ophthalmol 69(3):403-414
17. Kohner EM, Patel V, et al. (1995) Role of blood flow and impaired autoregulation in the pathogenesis of diabetic ret-inopathy. Diabetes 44(6):603-607
18. Ljubimov AV, Burgeson RE, et al. (1996) Basement membrane abnormalities in human eyes with diabetic retinopa-thy. J Histochem Cytochem 44(12):1469-1479
19. Gardiner TA, Archer DB, Curtis TM, Stitt AW (2007) Arteri-olar involvement in the microvascular lesions of diabetic retinopathy: implications for pathogenesis. Micorcircula-tion 14(1):25-38
20. Minshall RD, Sessa WC, et al. (2003) Caveolin regulation of endothelial function. Am J Physiol Lung Cell Mol Physiol 285(6):L1179-1183
21. Mizutani M, Kern TS, et al. (1996) Accelerated death of retinal microvascular cells in human and experimental diabetic retinopathy. J Clin Invest 97(12):2883-2890
22. Muraki K, Iwata Y, Katanosaka Y, Ito T, Ohya S, Shigekawa M, Imaizumi Y (2003) TRPV2 is a component of osmotical-ly sensitive cation channels in murine aortic myocytes. Circ Res 93(9):829-38
23. Nomura M, Yamagishi S, et al. (1995) Possible participation of autocrine and paracrine vascular endothelial growth factors in hypoxia-induced proliferation of endothelial cells and pericytes. J Biol Chem 270(47):28316-28324
24. Padayatti PS, Jiang C, et al. (2001) High concentrations of glucose induce synthesis of argpyrimidine in retinal endo-thelial cells. Curr Eye Res 23(2):106-115
25. Pierce EA, Avery RL, et al. (1995) Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularization. Proc Natl Acad Sci U S A 92(3):905-909
26. Polska E, Polak K, et al. (2004) Twelve hour reproducibility of choroidal blood flow parameters in healthy subjects. Br J Ophthalmol 88(4):533-537
27. Provis JM (2001) Development of the primate retinal vascu-lature. Prog Retin Eye Res 20(6):799-821
28. Roy S, Maiello M, et al. (1994) Increased expression of basement membrane collagen in human diabetic retinopathy. J Clin Invest 93(1):438-442
29. Saint-Geniez M, D'Amore PA (2004) Development and pathology of the hyaloid, choroidal and retinal vasculature. Int J Dev Biol 48(8-9):1045-1058
30. Schmetterer L, Wolzt M (1999) Ocular blood flow and associated functional deviations in diabetic retinopathy. Diabe-tologia 42(4):387-405
31. Sharma NK, Gardiner TA, et al. (1985) A morphologic and autoradiographic study of cell death and regeneration in the retinal microvasculature of normal and diabetic rats. Am J Ophthalmol 100(1):51-60
32. Stitt AW, Anderson HR, et al. (1994) Diabetic retinopathy: quantitative variation in capillary basement membrane thickening in arterial or venous environments. Br J Oph-thalmol 78(2):133-137
33. Stitt AW, Gardiner TA, et al. (1995) Histological and ultrastructural investigation of retinal microaneurysm development in diabetic patients. Br J Ophthalmol 79(4):362-367
34. Stitt AW, Gardiner TA, et al. (2002) The AGE inhibitor pyri-doxamine inhibits development of retinopathy in experimental diabetes. Diabetes 51(9):2826-2832
35. Stitt AW, Hughes SJ, et al. (2004) Substrates modified by advanced glycation end-products cause dysfunction and death in retinal pericytes by reducing survival signals mediated by platelet-derived growth factor. Diabetologia 47(10):1735-1746
36. Stone J, Itin A, et al. (1995) Development of retinal vascula-ture is mediated by hypoxia-induced vascular endothelial growth factor (VEGF) expression by neuroglia. J Neurosci 15(7):4738-4747
37. Tzekov R, Arden GB (1999) The electroretinogram in diabetic retinopathy. Surv Ophthalmol 44(1):53-60
38. vom Hagen F, Feng Y, et al. ( 2005) Early loss of arteriolar smooth muscle cells: more than just a pericyte loss in diabetic retinopathy. Exp Clin Endocrinol Diabetes 113( 10): 573-576
39. Wong TY, McIntosh R (2005) Hypertensive retinopathy signs as risk indicators of cardiovascular morbidity and mortality. Br Med Bull 73-74:57-70
40. Yanoff M (1966) Diabetic retinopathy. N Engl J Med 274(24):1344-1349
41. Yanoff M (1969) Ocular pathology of diabetes mellitus. Am J Ophthalmol 67(1):21-38